VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹54 Cr | ₹57 Cr | ₹48 Cr | ₹54 Cr | ₹58 Cr |
What is the latest Total Current Liabilities ratio of VIMTA LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹48 Cr |
| Mar2021 | ₹54 Cr |
| Mar2020 | ₹58 Cr |
How is Total Current Liabilities of VIMTA LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹54 Cr | -5.60 | |
| Mar2023 | ₹57 Cr | 19.95 | |
| Mar2022 | ₹48 Cr | -11.43 | |
| Mar2021 | ₹54 Cr | -6.34 | |
| Mar2020 | ₹58 Cr | - | |
Compare Total Current Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,477.1 Cr | -7.9% | -8.8% | 16.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -7.9% |
-8.8% |
16.8% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses